These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8386970)

  • 1. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat.
    Vezina P
    Brain Res; 1993 Mar; 605(2):332-7. PubMed ID: 8386970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine.
    Perugini M; Vezina P
    J Pharmacol Exp Ther; 1994 Aug; 270(2):690-6. PubMed ID: 8071860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
    Cador M; Bjijou Y; Stinus L
    Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats.
    Giorgetti M; Hotsenpiller G; Ward P; Teppen T; Wolf ME
    J Neurosci; 2001 Aug; 21(16):6362-9. PubMed ID: 11487659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.
    Vezina P; Stewart J
    Brain Res; 1990 May; 516(1):99-106. PubMed ID: 2364286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    Synapse; 1994 Feb; 16(2):104-12. PubMed ID: 8197574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
    Hu XT; Koeltzow TE; Cooper DC; Robertson GS; White FJ; Vezina P
    Synapse; 2002 Sep; 45(3):159-70. PubMed ID: 12112395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system.
    Koob GF; Stinus L; Le Moal M
    Behav Brain Res; 1981 Nov; 3(3):341-59. PubMed ID: 6796098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area.
    Vezina P
    J Neurosci; 1996 Apr; 16(7):2411-20. PubMed ID: 8601820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat.
    Panagis G; Nisell M; Nomikos GG; Chergui K; Svensson TH
    Brain Res; 1996 Aug; 730(1-2):133-42. PubMed ID: 8883897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.
    Robinson TE; Jurson PA; Bennett JA; Bentgen KM
    Brain Res; 1988 Oct; 462(2):211-22. PubMed ID: 2847849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.
    Vezina P; Lorrain DS; Arnold GM; Austin JD; Suto N
    J Neurosci; 2002 Jun; 22(11):4654-62. PubMed ID: 12040071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
    Vezina P; Queen AL
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat.
    Vezina P; Hervé D; Glowinski J; Tassin JP
    Neurosci Lett; 1994 Feb; 168(1-2):111-4. PubMed ID: 8028761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections.
    Ferrari R; Le Novère N; Picciotto MR; Changeux JP; Zoli M
    Eur J Neurosci; 2002 Jun; 15(11):1810-8. PubMed ID: 12081661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion.
    Deroche V; Marinelli M; Maccari S; Le Moal M; Simon H; Piazza PV
    J Neurosci; 1995 Nov; 15(11):7181-8. PubMed ID: 7472472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust sensitization to amphetamine following intra-VTA cholera toxin administration.
    Byrnes JJ; Weinstein DM; Wallace LJ
    Synapse; 1997 Apr; 25(4):335-44. PubMed ID: 9097392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
    Steinberg R; Brun P; Fournier M; Souilhac J; Rodier D; Mons G; Terranova JP; Le Fur G; Soubrié P
    Neuroscience; 1994 Apr; 59(4):921-9. PubMed ID: 8058127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.